Showing results (731-740 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|January 20, 2022
Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyEugene R Ahn, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology|January 20, 2022
Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer TherapyBryan P Schneider, Leigh Anne Stout, Santosh Philips, et al.
JCO Precision Oncology|January 20, 2022
Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast CancerMarko Velimirovic, Dejan Juric, Andrzej Niemierko, et al.
JCO Precision Oncology|February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell CarcinomaBradley A McGregor, Wanling Xie, Elio Adib, et al.
JCO Precision Oncology|February 17, 2022
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic AlgorithmAntonio Marchetti, Massimo Barberis, Alessia Di Lorito, et al.
JCO Precision Oncology|September 27, 2021
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary TumorsDavid J Einstein, Seiji Arai, Carla Calagua, et al.
JCO Precision Oncology|October 8, 2021
Molecular Tumor Board Review and Improved Overall Survival in Non-Small-Cell Lung CancerBin Huang, Quan Chen, Derek Allison, et al.
JCO Precision Oncology|February 9, 2022
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline BRCA or PALB2 MutationsKim A Reiss, Shun Yu, Renae Judy, et al.
JCO Precision Oncology|February 9, 2022
Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research RegistriesAlyssa L Smith, Cavin Wong, Adeline Cuggia, et al.
JCO Precision Oncology|February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Pageof 140